2018-2023 Global Dermatology Drugs Consumption Market Report

August 2018 | 161 pages | ID: 20F1C20ABF8EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Dermatology Drugs market for 2018-2023.

Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
Over the next five years, LPI(LP Information) projects that Dermatology Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• External Use
• Oral
• Injection

Segmentation by application:

• Psoriasis
• Skin Infections
• Acne
• Dermatitis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• AbbVie
• Johnson & Johnson
• Bayer
• Galderma
• Bristol-Myers Squibb
• Novartis
• Pfizer
• Merz Pharma
• Valeant
• LEO Pharma
• GlaxoSmithKline

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Dermatology Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Dermatology Drugs market by identifying its various subsegments.
• Focuses on the key global Dermatology Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Dermatology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Dermatology Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dermatology Drugs Consumption 2013-2023
  2.1.2 Dermatology Drugs Consumption CAGR by Region
2.2 Dermatology Drugs Segment by Type
  2.2.1 External Use
  2.2.2 Oral
  2.2.3 Injection
2.3 Dermatology Drugs Consumption by Type
  2.3.1 Global Dermatology Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Dermatology Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Dermatology Drugs Sale Price by Type (2013-2018)
2.4 Dermatology Drugs Segment by Application
  2.4.1 Psoriasis
  2.4.2 Skin Infections
  2.4.3 Acne
  2.4.4 Dermatitis
  2.4.5 Other
2.5 Dermatology Drugs Consumption by Application
  2.5.1 Global Dermatology Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Dermatology Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Dermatology Drugs Sale Price by Application (2013-2018)

3 GLOBAL DERMATOLOGY DRUGS BY PLAYERS

3.1 Global Dermatology Drugs Sales Market Share by Players
  3.1.1 Global Dermatology Drugs Sales by Players (2016-2018)
  3.1.2 Global Dermatology Drugs Sales Market Share by Players (2016-2018)
3.2 Global Dermatology Drugs Revenue Market Share by Players
  3.2.1 Global Dermatology Drugs Revenue by Players (2016-2018)
  3.2.2 Global Dermatology Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Dermatology Drugs Sale Price by Players
3.4 Global Dermatology Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Dermatology Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Dermatology Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 DERMATOLOGY DRUGS BY REGIONS

4.1 Dermatology Drugs by Regions
  4.1.1 Global Dermatology Drugs Consumption by Regions
  4.1.2 Global Dermatology Drugs Value by Regions
4.2 Americas Dermatology Drugs Consumption Growth
4.3 APAC Dermatology Drugs Consumption Growth
4.4 Europe Dermatology Drugs Consumption Growth
4.5 Middle East & Africa Dermatology Drugs Consumption Growth

5 AMERICAS

5.1 Americas Dermatology Drugs Consumption by Countries
  5.1.1 Americas Dermatology Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Dermatology Drugs Value by Countries (2013-2018)
5.2 Americas Dermatology Drugs Consumption by Type
5.3 Americas Dermatology Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Dermatology Drugs Consumption by Countries
  6.1.1 APAC Dermatology Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Dermatology Drugs Value by Countries (2013-2018)
6.2 APAC Dermatology Drugs Consumption by Type
6.3 APAC Dermatology Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Dermatology Drugs by Countries
  7.1.1 Europe Dermatology Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Dermatology Drugs Value by Countries (2013-2018)
7.2 Europe Dermatology Drugs Consumption by Type
7.3 Europe Dermatology Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dermatology Drugs by Countries
  8.1.1 Middle East & Africa Dermatology Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Dermatology Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Dermatology Drugs Consumption by Type
8.3 Middle East & Africa Dermatology Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Dermatology Drugs Distributors
10.3 Dermatology Drugs Customer

11 GLOBAL DERMATOLOGY DRUGS MARKET FORECAST

11.1 Global Dermatology Drugs Consumption Forecast (2018-2023)
11.2 Global Dermatology Drugs Forecast by Regions
  11.2.1 Global Dermatology Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Dermatology Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Dermatology Drugs Forecast by Type
11.8 Global Dermatology Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 AbbVie
  12.1.1 Company Details
  12.1.2 Dermatology Drugs Product Offered
  12.1.3 AbbVie Dermatology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 AbbVie News
12.2 Johnson & Johnson
  12.2.1 Company Details
  12.2.2 Dermatology Drugs Product Offered
  12.2.3 Johnson & Johnson Dermatology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Johnson & Johnson News
12.3 Bayer
  12.3.1 Company Details
  12.3.2 Dermatology Drugs Product Offered
  12.3.3 Bayer Dermatology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Bayer News
12.4 Galderma
  12.4.1 Company Details
  12.4.2 Dermatology Drugs Product Offered
  12.4.3 Galderma Dermatology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Galderma News
12.5 Bristol-Myers Squibb
  12.5.1 Company Details
  12.5.2 Dermatology Drugs Product Offered
  12.5.3 Bristol-Myers Squibb Dermatology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Bristol-Myers Squibb News
12.6 Novartis
  12.6.1 Company Details
  12.6.2 Dermatology Drugs Product Offered
  12.6.3 Novartis Dermatology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Novartis News
12.7 Pfizer
  12.7.1 Company Details
  12.7.2 Dermatology Drugs Product Offered
  12.7.3 Pfizer Dermatology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Pfizer News
12.8 Merz Pharma
  12.8.1 Company Details
  12.8.2 Dermatology Drugs Product Offered
  12.8.3 Merz Pharma Dermatology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Merz Pharma News
12.9 Valeant
  12.9.1 Company Details
  12.9.2 Dermatology Drugs Product Offered
  12.9.3 Valeant Dermatology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Valeant News
12.10 LEO Pharma
  12.10.1 Company Details
  12.10.2 Dermatology Drugs Product Offered
  12.10.3 LEO Pharma Dermatology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 LEO Pharma News
12.11 GlaxoSmithKline

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Dermatology Drugs
Table Product Specifications of Dermatology Drugs
Figure Dermatology Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Dermatolog